NEW YORK (GenomeWeb News) – Oxford Nanopore has raised £17.4 million ($28 million) in a new round of funding through existing and new investors and its marketing partner Illumina UK.

The firm is developing a nanopore-based, single-molecule sequencing platform and said that it will use the funds to accelerate development of the technology. It also said that it would use funds to support its lead project in DNA sequencing and to start early work in protein analysis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.